Pyelonephritis diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
Line 25: | Line 25: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Specificity | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Specificity | ||
|- | |- | ||
! rowspan="7" |Urinalysis | ! rowspan="7" style="background: #696969; color: #FFFFFF; text-align: center;" |Urinalysis | ||
! rowspan="2" |WBC | ! rowspan="2" style="background: #696969; color: #FFFFFF; text-align: center;" |WBC | ||
| colspan="1" rowspan="1" style="background: #696969; color: #FFFFFF; text-align: center;" |> 5 WBCs/HPF | | colspan="1" rowspan="1" style="background: #696969; color: #FFFFFF; text-align: center;" |> 5 WBCs/HPF | ||
| colspan="1" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |72-95% | | colspan="1" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |72-95% | ||
Line 35: | Line 35: | ||
| colspan="1" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |65-86% | | colspan="1" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |65-86% | ||
|- | |- | ||
!RBC | ! style="background: #696969; color: #FFFFFF; text-align: center;" |RBC | ||
| colspan="1" rowspan="1" | + | | colspan="1" rowspan="1" style="background: #696969; color: #FFFFFF; text-align: center;" |+ | ||
| colspan="1" rowspan="1" |44% | | colspan="1" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |44% | ||
| colspan="1" rowspan="1" |88% | | colspan="1" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |88% | ||
|- | |- | ||
! colspan="1" rowspan="1" style="background: #696969; color: #FFFFFF; text-align: center;" |Leukocyte esterase test | |||
| colspan="1" rowspan="1" | + | | colspan="1" rowspan="1" style="background: #696969; color: #FFFFFF; text-align: center;" | + | ||
| colspan="1" rowspan="1" |74-96% | | colspan="1" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |74-96% | ||
| colspan="1" rowspan="1" |94-98% | | colspan="1" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |94-98% | ||
|- | |- | ||
! colspan="1" rowspan="1" style="background: #696969; color: #FFFFFF; text-align: center;" |Nitrite test | |||
| colspan="1" rowspan="1" | + | | colspan="1" rowspan="1" style="background: #696969; color: #FFFFFF; text-align: center;" | + | ||
| colspan="1" rowspan="1" |35-85% | | colspan="1" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |35-85% | ||
| colspan="1" rowspan="1" |92-100% | | colspan="1" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |92-100% | ||
|- | |- | ||
! colspan="1" rowspan="1" style="background: #696969; color: #FFFFFF; text-align: center;" |Combination leukocyte esterase and nitrite tests | |||
| colspan="1" rowspan="1" |Either test + | | colspan="1" rowspan="1" style="background: #696969; color: #FFFFFF; text-align: center;" |Either test + | ||
| colspan="1" rowspan="1" |75-84% | | colspan="1" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |75-84% | ||
| colspan="1" rowspan="1" |82-98% | | colspan="1" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |82-98% | ||
|- | |- | ||
! colspan="1" rowspan="1" style="background: #696969; color: #FFFFFF; text-align: center;" |Gram stain of uncentrifuged urine | |||
| colspan="1" rowspan="1" |> 1 bacterium per HPF | | colspan="1" rowspan="1" style="background: #696969; color: #FFFFFF; text-align: center;" |> 1 bacterium per HPF | ||
| colspan="1" rowspan="1" |93% | | colspan="1" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |93% | ||
| colspan="1" rowspan="1" |95% | | colspan="1" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |95% | ||
|- | |- | ||
! colspan="2" |Urine culture | ! colspan="2" style="background: #696969; color: #FFFFFF; text-align: center;" |Urine culture | ||
| style="background: #696969; color: #FFFFFF; text-align: center;" |+ | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |90% | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | |||
|- | |- | ||
! colspan="2" |Blood culture | ! colspan="2" style="background: #696969; color: #FFFFFF; text-align: center;" |Blood culture | ||
| style="background: #696969; color: #FFFFFF; text-align: center;" |+ | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |20% | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | |||
|} | |} | ||
Revision as of 19:20, 12 June 2018
Pyelonephritis Microchapters |
Diagnosis |
Treatment |
Case Studies |
Pyelonephritis diagnostic study of choice On the Web |
American Roentgen Ray Society Images of Pyelonephritis diagnostic study of choice |
Risk calculators and risk factors for Pyelonephritis diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Diagnostic Study of Choice
Study of choice
- There is no single diagnostic study of choice for the diagnosis of pyelonephritis.
- Pyelonephritis must be suspected if the patient has urinary symptoms including dysuria, urgency, frequency, or suprapubic pain, along with fever, chills, flank pain, pelvic or perineal pain.
- Urinalysis and urine culture with susceptibility testing might support the diagnosis.
- Imaging would not be necessary for patients with pyelonephritis, unless in patients with severe and refractory illness or suspected urinary tract obstruction.
- There is no single diagnostic study of choice for the diagnosis of [disease name], but [disease name] can be diagnosed based on [name of the investigation 1] and [name of the investigation 2].
- [Disease name] is mainly diagnosed based on clinical presentation.
- Investigations:
- Among patients who present with clinical signs of [disease name], the [investigation name] is the most specific test for the diagnosis.
- Among patients who present with clinical signs of [disease name], the [investigation name] is the most sensitive test for diagnosis.
- Among patients who present with clinical signs of [disease name], the [investigation name] is the most efficient test for diagnosis.
The comparison of various diagnostic studies for [disease name]
Test | Sensitivity | Specificity | ||
---|---|---|---|---|
Urinalysis | WBC | > 5 WBCs/HPF | 72-95% | 48-82% |
> 10 WBCs/HPF | 58-82% | 65-86% | ||
RBC | + | 44% | 88% | |
Leukocyte esterase test | + | 74-96% | 94-98% | |
Nitrite test | + | 35-85% | 92-100% | |
Combination leukocyte esterase and nitrite tests | Either test + | 75-84% | 82-98% | |
Gram stain of uncentrifuged urine | > 1 bacterium per HPF | 93% | 95% | |
Urine culture | + | 90% | ||
Blood culture | + | 20% |
Diagnostic results
The following result of [investigation name] is confirmatory of [disease name]:
- Result 1
- Result 2
Sequence of Diagnostic Studies
The [name of investigation] should be performed when:
- The patient presented with symptoms/signs 1, 2, and 3 as the first step of diagnosis.
- A positive [test] is detected in the patient, to confirm the diagnosis.
Diagnostic Criteria
- Here you should describe the details of the diagnostic criteria.
- Always mention the name of the criteria/definition you are about to list (e.g. modified Duke criteria for the diagnosis of endocarditis / 3rd universal definition of MI) and cite the primary source of where this criteria/definition is found.
- Although not necessary, it is recommended that you include the criteria in a table. Make sure you always cite the source of the content and whether the table has been adapted from another source.
- Be very clear as to the number of criteria (or threshold) that needs to be met out of the total number of criteria.
- Distinguish criteria based on their nature (e.g. clinical criteria / pathological criteria/ imaging criteria) before discussing them in details.
- To view an example (endocarditis diagnostic criteria), click here
- If relevant, add additional information that might help the reader distinguish various criteria or the evolution of criteria (e.g. original criteria vs. modified criteria).
- You may also add information about the sensitivity and specificity of the criteria, the pre-test probability, and other figures that may help the reader understand how valuable the criteria are clinically.
- [Disease name] is mainly diagnosed based on clinical presentation. There are no established criteria for the diagnosis of [disease name].
- There is no single diagnostic study of choice for [disease name], though [disease name] may be diagnosed based on [name of criteria] established by [...].
- The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
- The diagnosis of [disease name] is based on the [criteria name] criteria, which includes [criterion 1], [criterion 2], and [criterion 3].
- [Disease name] may be diagnosed at any time if one or more of the following criteria are met:
- Criteria 1
- Criteria 2
- Criteria 3
IF there are clear, established diagnostic criteria:
- The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
- The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].
- The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].
IF there are no established diagnostic criteria:
- There are no established criteria for the diagnosis of [disease name].